SlideShare una empresa de Scribd logo
1 de 34
Management of Women with Abnormal Pap Test
Bethesda System 2001 ,[object Object],[object Object],[object Object],[object Object]
Bethesda System 2001 ,[object Object],[object Object],[object Object],[object Object],[object Object]
Comparison of Terminology  Bethesda System CIN system Dysplasia ASCUS Cellular Atypia Unspecified Cellular  changes LSIL CIN I Mild Dysplasia HSIL CIN II Moderate dysplasia CIN III Severe Dysplasia/ CIS
Management strategy depends  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Abnormal Pap test ASCUS LSIL HSIL HPV –ve HPV +ve Rpt Pap Negative Colposcopy LEEP ECC +ve -ve Treat & Follow up Diagnostic cone Treat & Follow up
ATYPICAL SQUAMOUS CELLS
ATYPICAL SQUAMOUS CELLS ,[object Object],[object Object],[object Object],[object Object],[object Object]
ASC-US ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Recommended Management of Women with ASC-US ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Rpt Cytology @ 6 & 12 Months  HPV –ve HPV +ve Rpt Cytology @ 12 months Colposcopy  ECC if no lesions or unsatisfactory colpo  No CIN CIN Repeat Cytology  @ 6, 12 months  Or  HPV DNA test @12 months Treat & follow up ASCUS
Recommended Management  of ASC-US ,[object Object],[object Object],[object Object]
Recommended Management of Women with ASC-H  (CANNOT EXCLUDE HSIL) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
ASC-H Colposcopy ECC if no lesions  or unsatisfactory colpo CIN 2,3 > ASC or HPV+ Treat & Follow up Rpt Cytology @ 6, 12 months   OR HPV DNA Test @ 12 mths No CIN 2,3  Colposcopy Negative  Routine screening
Low Grade SIL
LSIL  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
LSIL  ,[object Object],[object Object],[object Object],[object Object],[object Object]
LSIL Colposcopy Negative Unsatisfactory colpo No lesion Satisfactory Colpo Lesion in TZ ECC No CIN CIN 2,3 Cytology @ 6, 12 mths OR HPV testing Treat & Follow up
LSIL – Post Colposcopy Management ,[object Object]
HIGH GRADE SIL HSIL
High-grade Squamous Intraepithelial Lesion (HSIL) ,[object Object],[object Object],[object Object],[object Object]
HSIL Colposcopy ECC Unsatisfactory colpo Satisfactory Colpo No CIN 2,3 Diagnostic  Excisional procedure Observe with  Cytology / Colposcopy  Treat & Follow up LEEP CIN 2,3
Managing Women with HSIL UNACCEPTABLE STRATEGIES ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
SIL in Pregnancy ,[object Object],[object Object],[object Object],[object Object],[object Object]
SIL in Pregnancy ,[object Object],[object Object],[object Object],[object Object]
ASCUS & LSIL in ADOLESCENTS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
LSIL in POSTMENOPAUSAL WOMEN ,[object Object],[object Object],[object Object],[object Object]
ATYPICAL Glandular Cells
ATYPICAL GLANDULAR CELLS  ,[object Object],[object Object],[object Object]
ATYPICAL GLANDULAR CELLS  ,[object Object],[object Object],[object Object],[object Object]
ATYPICAL GLANDULAR CELLS  ,[object Object],[object Object],[object Object],[object Object],[object Object]
AIS Hysterectomy preferred Margins involved ECC +ve Reexcision  recommended Long term  Follow up Diagnostic excisional procedure If future fertility desired Conservative Management Margins negative
Management of CIN ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
TOP 10 KEY POINTS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Más contenido relacionado

La actualidad más candente

Premalignant and malignant conditions of the cervix
Premalignant and malignant conditions  of the cervix  Premalignant and malignant conditions  of the cervix
Premalignant and malignant conditions of the cervix tariggally
 
Atlas on bethesda system for reporting cervical cytology
Atlas on bethesda system for reporting cervical cytologyAtlas on bethesda system for reporting cervical cytology
Atlas on bethesda system for reporting cervical cytologyAshish Jawarkar
 
Benign n pre malignant diseases of cx
Benign n pre malignant diseases of cxBenign n pre malignant diseases of cx
Benign n pre malignant diseases of cxParika Tanwar
 
Cervical intraepithelial neoplasia
Cervical intraepithelial neoplasiaCervical intraepithelial neoplasia
Cervical intraepithelial neoplasiadrmcbansal
 
Initial Evaluation and Referral Guidelines for Management of Pelvic/Ovarian M...
Initial Evaluation and Referral Guidelines for Management of Pelvic/Ovarian M...Initial Evaluation and Referral Guidelines for Management of Pelvic/Ovarian M...
Initial Evaluation and Referral Guidelines for Management of Pelvic/Ovarian M...Aboubakr Elnashar
 
Cervical intra epithelial neoplasia
Cervical intra epithelial neoplasiaCervical intra epithelial neoplasia
Cervical intra epithelial neoplasiaAboubakr Elnashar
 
Screening for cervical cancer
Screening for  cervical cancerScreening for  cervical cancer
Screening for cervical cancerAboubakr Elnashar
 
Say no to cervical cancer-PUBLIC Awareness-Life Care Centre_Dr.Sharda Jain
Say no to cervical cancer-PUBLIC Awareness-Life Care Centre_Dr.Sharda JainSay no to cervical cancer-PUBLIC Awareness-Life Care Centre_Dr.Sharda Jain
Say no to cervical cancer-PUBLIC Awareness-Life Care Centre_Dr.Sharda JainLifecare Centre
 
Colposcopy case studies2
Colposcopy case studies2Colposcopy case studies2
Colposcopy case studies2Tariq Mohammed
 
Fertility Preservation for Gynecologic Cancer Patients
Fertility Preservation for Gynecologic Cancer PatientsFertility Preservation for Gynecologic Cancer Patients
Fertility Preservation for Gynecologic Cancer PatientsJibran Mohsin
 
Carcinoma Endometrium DR H.K.Cheema Professor-OBG,PIMS Jalandhar
Carcinoma Endometrium   DR H.K.Cheema Professor-OBG,PIMS JalandharCarcinoma Endometrium   DR H.K.Cheema Professor-OBG,PIMS Jalandhar
Carcinoma Endometrium DR H.K.Cheema Professor-OBG,PIMS JalandharDr H.K. Cheema
 
Initiatives of elimination of Cervical cancer in India so far : Guidelines...
Initiatives of elimination of  Cervical cancer in India  so far :  Guidelines...Initiatives of elimination of  Cervical cancer in India  so far :  Guidelines...
Initiatives of elimination of Cervical cancer in India so far : Guidelines...Lifecare Centre
 
Cervical Screening State of the Art 2016
Cervical Screening State of the Art 2016Cervical Screening State of the Art 2016
Cervical Screening State of the Art 2016Dr Dirk Grothuesmann
 

La actualidad más candente (20)

Bethesda Cervical CYtology
Bethesda Cervical CYtologyBethesda Cervical CYtology
Bethesda Cervical CYtology
 
HPV and Cervical Cancer Screening
HPV and Cervical Cancer ScreeningHPV and Cervical Cancer Screening
HPV and Cervical Cancer Screening
 
germ cell tumours of ovary
germ cell tumours of ovarygerm cell tumours of ovary
germ cell tumours of ovary
 
Bethesda system for reporting
Bethesda system for reportingBethesda system for reporting
Bethesda system for reporting
 
Endometrial cancer
Endometrial cancerEndometrial cancer
Endometrial cancer
 
Premalignant and malignant conditions of the cervix
Premalignant and malignant conditions  of the cervix  Premalignant and malignant conditions  of the cervix
Premalignant and malignant conditions of the cervix
 
Atlas on bethesda system for reporting cervical cytology
Atlas on bethesda system for reporting cervical cytologyAtlas on bethesda system for reporting cervical cytology
Atlas on bethesda system for reporting cervical cytology
 
Radical hysterectomy
Radical hysterectomyRadical hysterectomy
Radical hysterectomy
 
Benign n pre malignant diseases of cx
Benign n pre malignant diseases of cxBenign n pre malignant diseases of cx
Benign n pre malignant diseases of cx
 
Cervical intraepithelial neoplasia
Cervical intraepithelial neoplasiaCervical intraepithelial neoplasia
Cervical intraepithelial neoplasia
 
Initial Evaluation and Referral Guidelines for Management of Pelvic/Ovarian M...
Initial Evaluation and Referral Guidelines for Management of Pelvic/Ovarian M...Initial Evaluation and Referral Guidelines for Management of Pelvic/Ovarian M...
Initial Evaluation and Referral Guidelines for Management of Pelvic/Ovarian M...
 
Cervical intra epithelial neoplasia
Cervical intra epithelial neoplasiaCervical intra epithelial neoplasia
Cervical intra epithelial neoplasia
 
Screening for cervical cancer
Screening for  cervical cancerScreening for  cervical cancer
Screening for cervical cancer
 
Madhuri ppt path
Madhuri ppt pathMadhuri ppt path
Madhuri ppt path
 
Say no to cervical cancer-PUBLIC Awareness-Life Care Centre_Dr.Sharda Jain
Say no to cervical cancer-PUBLIC Awareness-Life Care Centre_Dr.Sharda JainSay no to cervical cancer-PUBLIC Awareness-Life Care Centre_Dr.Sharda Jain
Say no to cervical cancer-PUBLIC Awareness-Life Care Centre_Dr.Sharda Jain
 
Colposcopy case studies2
Colposcopy case studies2Colposcopy case studies2
Colposcopy case studies2
 
Fertility Preservation for Gynecologic Cancer Patients
Fertility Preservation for Gynecologic Cancer PatientsFertility Preservation for Gynecologic Cancer Patients
Fertility Preservation for Gynecologic Cancer Patients
 
Carcinoma Endometrium DR H.K.Cheema Professor-OBG,PIMS Jalandhar
Carcinoma Endometrium   DR H.K.Cheema Professor-OBG,PIMS JalandharCarcinoma Endometrium   DR H.K.Cheema Professor-OBG,PIMS Jalandhar
Carcinoma Endometrium DR H.K.Cheema Professor-OBG,PIMS Jalandhar
 
Initiatives of elimination of Cervical cancer in India so far : Guidelines...
Initiatives of elimination of  Cervical cancer in India  so far :  Guidelines...Initiatives of elimination of  Cervical cancer in India  so far :  Guidelines...
Initiatives of elimination of Cervical cancer in India so far : Guidelines...
 
Cervical Screening State of the Art 2016
Cervical Screening State of the Art 2016Cervical Screening State of the Art 2016
Cervical Screening State of the Art 2016
 

Destacado (6)

Pap smear
Pap smearPap smear
Pap smear
 
Pap smear guide
Pap smear guidePap smear guide
Pap smear guide
 
PAP test methods
PAP test methods PAP test methods
PAP test methods
 
Pap smear test
Pap smear testPap smear test
Pap smear test
 
Pap smear
Pap smear Pap smear
Pap smear
 
Pap Smear
Pap SmearPap Smear
Pap Smear
 

Similar a Abnormal Pap Test

Cervical Cancer Screening
Cervical Cancer ScreeningCervical Cancer Screening
Cervical Cancer Screeningsarahmccorm
 
4 prof james bently management guidelines 2014
4  prof james bently management guidelines 20144  prof james bently management guidelines 2014
4 prof james bently management guidelines 2014Tariq Mohammed
 
Servikal Displazi -Pap Smear - Serviks Kanseri - www.jinekolojivegebelik.com
Servikal Displazi -Pap Smear - Serviks Kanseri - www.jinekolojivegebelik.comServikal Displazi -Pap Smear - Serviks Kanseri - www.jinekolojivegebelik.com
Servikal Displazi -Pap Smear - Serviks Kanseri - www.jinekolojivegebelik.comjinekolojivegebelik.com
 
Cervical Cancer Screening
Cervical Cancer ScreeningCervical Cancer Screening
Cervical Cancer ScreeningClinton Pong
 
Cervical ca screening ..
Cervical ca screening ..Cervical ca screening ..
Cervical ca screening ..med_students0
 
Ovarian cancer .pptx
Ovarian cancer .pptxOvarian cancer .pptx
Ovarian cancer .pptxDeveshAhir
 
Ovarian cancer .pptx
Ovarian cancer .pptxOvarian cancer .pptx
Ovarian cancer .pptxDeveshAhir
 
understandingtestresutsbbhvvhhgddghvgAP.ppt
understandingtestresutsbbhvvhhgddghvgAP.pptunderstandingtestresutsbbhvvhhgddghvgAP.ppt
understandingtestresutsbbhvvhhgddghvgAP.pptnasriddinovaranokhon
 
fdokumen.com_lesi-pra-kanker-58e8d544505fe.ppt
fdokumen.com_lesi-pra-kanker-58e8d544505fe.pptfdokumen.com_lesi-pra-kanker-58e8d544505fe.ppt
fdokumen.com_lesi-pra-kanker-58e8d544505fe.pptssuser6eec60
 
NHSCSP cervical screening program and treatment of CIN and CGIN
NHSCSP cervical screening program and treatment of CIN and CGINNHSCSP cervical screening program and treatment of CIN and CGIN
NHSCSP cervical screening program and treatment of CIN and CGINWai Phyo
 
Lesi Pra Kanker (wecompress.com).ppt
Lesi Pra Kanker (wecompress.com).pptLesi Pra Kanker (wecompress.com).ppt
Lesi Pra Kanker (wecompress.com).pptSTIKESSENIORSARJANAK
 
CANCER SCREENING AND NCCP.pptx
CANCER SCREENING AND NCCP.pptxCANCER SCREENING AND NCCP.pptx
CANCER SCREENING AND NCCP.pptxKiran Ramakrishna
 
Management of diseases of cervix
Management of diseases of cervixManagement of diseases of cervix
Management of diseases of cervixBasitAli254
 
Cervical Cancer Screening - HPV - www.jinekolojivegebelik.com
Cervical Cancer Screening - HPV - www.jinekolojivegebelik.comCervical Cancer Screening - HPV - www.jinekolojivegebelik.com
Cervical Cancer Screening - HPV - www.jinekolojivegebelik.comjinekolojivegebelik.com
 
Cervical cancer screening guidelines 2013 on 7th sept
Cervical cancer screening guidelines 2013 on 7th septCervical cancer screening guidelines 2013 on 7th sept
Cervical cancer screening guidelines 2013 on 7th septLifecare Centre
 

Similar a Abnormal Pap Test (20)

Cervical Cancer Screening
Cervical Cancer ScreeningCervical Cancer Screening
Cervical Cancer Screening
 
4 prof james bently management guidelines 2014
4  prof james bently management guidelines 20144  prof james bently management guidelines 2014
4 prof james bently management guidelines 2014
 
Servikal Displazi -Pap Smear - Serviks Kanseri - www.jinekolojivegebelik.com
Servikal Displazi -Pap Smear - Serviks Kanseri - www.jinekolojivegebelik.comServikal Displazi -Pap Smear - Serviks Kanseri - www.jinekolojivegebelik.com
Servikal Displazi -Pap Smear - Serviks Kanseri - www.jinekolojivegebelik.com
 
Cervical Cancer Screening
Cervical Cancer ScreeningCervical Cancer Screening
Cervical Cancer Screening
 
Cervical ca screening ..
Cervical ca screening ..Cervical ca screening ..
Cervical ca screening ..
 
Ovarian cancer .pptx
Ovarian cancer .pptxOvarian cancer .pptx
Ovarian cancer .pptx
 
Ovarian cancer .pptx
Ovarian cancer .pptxOvarian cancer .pptx
Ovarian cancer .pptx
 
LESI PRA KANKER
LESI PRA KANKERLESI PRA KANKER
LESI PRA KANKER
 
understandingtestresutsbbhvvhhgddghvgAP.ppt
understandingtestresutsbbhvvhhgddghvgAP.pptunderstandingtestresutsbbhvvhhgddghvgAP.ppt
understandingtestresutsbbhvvhhgddghvgAP.ppt
 
fdokumen.com_lesi-pra-kanker-58e8d544505fe.ppt
fdokumen.com_lesi-pra-kanker-58e8d544505fe.pptfdokumen.com_lesi-pra-kanker-58e8d544505fe.ppt
fdokumen.com_lesi-pra-kanker-58e8d544505fe.ppt
 
NHSCSP cervical screening program and treatment of CIN and CGIN
NHSCSP cervical screening program and treatment of CIN and CGINNHSCSP cervical screening program and treatment of CIN and CGIN
NHSCSP cervical screening program and treatment of CIN and CGIN
 
Lesi Pra Kanker (wecompress.com).ppt
Lesi Pra Kanker (wecompress.com).pptLesi Pra Kanker (wecompress.com).ppt
Lesi Pra Kanker (wecompress.com).ppt
 
CANCER SCREENING AND NCCP.pptx
CANCER SCREENING AND NCCP.pptxCANCER SCREENING AND NCCP.pptx
CANCER SCREENING AND NCCP.pptx
 
Management of diseases of cervix
Management of diseases of cervixManagement of diseases of cervix
Management of diseases of cervix
 
Cancer ovarian .pptx
Cancer ovarian .pptxCancer ovarian .pptx
Cancer ovarian .pptx
 
Cancer Screening
Cancer ScreeningCancer Screening
Cancer Screening
 
AUTOMOTIVE.PDF
AUTOMOTIVE.PDFAUTOMOTIVE.PDF
AUTOMOTIVE.PDF
 
Cervical Cancer Screening - HPV - www.jinekolojivegebelik.com
Cervical Cancer Screening - HPV - www.jinekolojivegebelik.comCervical Cancer Screening - HPV - www.jinekolojivegebelik.com
Cervical Cancer Screening - HPV - www.jinekolojivegebelik.com
 
Cervical cancer screening guidelines 2013 on 7th sept
Cervical cancer screening guidelines 2013 on 7th septCervical cancer screening guidelines 2013 on 7th sept
Cervical cancer screening guidelines 2013 on 7th sept
 
Breast screening
Breast screeningBreast screening
Breast screening
 

Más de drsubir

Cervical Cancer Disease Burden
Cervical Cancer Disease BurdenCervical Cancer Disease Burden
Cervical Cancer Disease Burdendrsubir
 
Colposcopy
ColposcopyColposcopy
Colposcopydrsubir
 
Hpv Sample Collection Procedure
Hpv Sample Collection ProcedureHpv Sample Collection Procedure
Hpv Sample Collection Proceduredrsubir
 
Human Papilloma Virus
Human Papilloma VirusHuman Papilloma Virus
Human Papilloma Virusdrsubir
 
Truscreen
TruscreenTruscreen
Truscreendrsubir
 

Más de drsubir (6)

Cervical Cancer Disease Burden
Cervical Cancer Disease BurdenCervical Cancer Disease Burden
Cervical Cancer Disease Burden
 
Colposcopy
ColposcopyColposcopy
Colposcopy
 
Hpv Sample Collection Procedure
Hpv Sample Collection ProcedureHpv Sample Collection Procedure
Hpv Sample Collection Procedure
 
Human Papilloma Virus
Human Papilloma VirusHuman Papilloma Virus
Human Papilloma Virus
 
Truscreen
TruscreenTruscreen
Truscreen
 
Via
ViaVia
Via
 

Último

Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...Orbitshub
 
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc
 
Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...
Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...
Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...apidays
 
"I see eyes in my soup": How Delivery Hero implemented the safety system for ...
"I see eyes in my soup": How Delivery Hero implemented the safety system for ..."I see eyes in my soup": How Delivery Hero implemented the safety system for ...
"I see eyes in my soup": How Delivery Hero implemented the safety system for ...Zilliz
 
Six Myths about Ontologies: The Basics of Formal Ontology
Six Myths about Ontologies: The Basics of Formal OntologySix Myths about Ontologies: The Basics of Formal Ontology
Six Myths about Ontologies: The Basics of Formal Ontologyjohnbeverley2021
 
Elevate Developer Efficiency & build GenAI Application with Amazon Q​
Elevate Developer Efficiency & build GenAI Application with Amazon Q​Elevate Developer Efficiency & build GenAI Application with Amazon Q​
Elevate Developer Efficiency & build GenAI Application with Amazon Q​Bhuvaneswari Subramani
 
DBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDropbox
 
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...apidays
 
[BuildWithAI] Introduction to Gemini.pdf
[BuildWithAI] Introduction to Gemini.pdf[BuildWithAI] Introduction to Gemini.pdf
[BuildWithAI] Introduction to Gemini.pdfSandro Moreira
 
Strategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a FresherStrategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a FresherRemote DBA Services
 
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...Jeffrey Haguewood
 
Platformless Horizons for Digital Adaptability
Platformless Horizons for Digital AdaptabilityPlatformless Horizons for Digital Adaptability
Platformless Horizons for Digital AdaptabilityWSO2
 
AWS Community Day CPH - Three problems of Terraform
AWS Community Day CPH - Three problems of TerraformAWS Community Day CPH - Three problems of Terraform
AWS Community Day CPH - Three problems of TerraformAndrey Devyatkin
 
Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Finding Java's Hidden Performance Traps @ DevoxxUK 2024Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Finding Java's Hidden Performance Traps @ DevoxxUK 2024Victor Rentea
 
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...DianaGray10
 
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWEREMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWERMadyBayot
 
Corporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptxCorporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptxRustici Software
 
Why Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire businessWhy Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire businesspanagenda
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FMESafe Software
 

Último (20)

Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
 
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
 
Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...
Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...
Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...
 
"I see eyes in my soup": How Delivery Hero implemented the safety system for ...
"I see eyes in my soup": How Delivery Hero implemented the safety system for ..."I see eyes in my soup": How Delivery Hero implemented the safety system for ...
"I see eyes in my soup": How Delivery Hero implemented the safety system for ...
 
Six Myths about Ontologies: The Basics of Formal Ontology
Six Myths about Ontologies: The Basics of Formal OntologySix Myths about Ontologies: The Basics of Formal Ontology
Six Myths about Ontologies: The Basics of Formal Ontology
 
Elevate Developer Efficiency & build GenAI Application with Amazon Q​
Elevate Developer Efficiency & build GenAI Application with Amazon Q​Elevate Developer Efficiency & build GenAI Application with Amazon Q​
Elevate Developer Efficiency & build GenAI Application with Amazon Q​
 
DBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor Presentation
 
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
 
[BuildWithAI] Introduction to Gemini.pdf
[BuildWithAI] Introduction to Gemini.pdf[BuildWithAI] Introduction to Gemini.pdf
[BuildWithAI] Introduction to Gemini.pdf
 
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
 
Strategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a FresherStrategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a Fresher
 
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
 
Platformless Horizons for Digital Adaptability
Platformless Horizons for Digital AdaptabilityPlatformless Horizons for Digital Adaptability
Platformless Horizons for Digital Adaptability
 
AWS Community Day CPH - Three problems of Terraform
AWS Community Day CPH - Three problems of TerraformAWS Community Day CPH - Three problems of Terraform
AWS Community Day CPH - Three problems of Terraform
 
Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Finding Java's Hidden Performance Traps @ DevoxxUK 2024Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Finding Java's Hidden Performance Traps @ DevoxxUK 2024
 
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
 
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWEREMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
 
Corporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptxCorporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptx
 
Why Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire businessWhy Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire business
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
 

Abnormal Pap Test

  • 1. Management of Women with Abnormal Pap Test
  • 2.
  • 3.
  • 4. Comparison of Terminology Bethesda System CIN system Dysplasia ASCUS Cellular Atypia Unspecified Cellular changes LSIL CIN I Mild Dysplasia HSIL CIN II Moderate dysplasia CIN III Severe Dysplasia/ CIS
  • 5.
  • 6. Abnormal Pap test ASCUS LSIL HSIL HPV –ve HPV +ve Rpt Pap Negative Colposcopy LEEP ECC +ve -ve Treat & Follow up Diagnostic cone Treat & Follow up
  • 8.
  • 9.
  • 10.
  • 11. Rpt Cytology @ 6 & 12 Months HPV –ve HPV +ve Rpt Cytology @ 12 months Colposcopy ECC if no lesions or unsatisfactory colpo No CIN CIN Repeat Cytology @ 6, 12 months Or HPV DNA test @12 months Treat & follow up ASCUS
  • 12.
  • 13.
  • 14. ASC-H Colposcopy ECC if no lesions or unsatisfactory colpo CIN 2,3 > ASC or HPV+ Treat & Follow up Rpt Cytology @ 6, 12 months OR HPV DNA Test @ 12 mths No CIN 2,3 Colposcopy Negative Routine screening
  • 16.
  • 17.
  • 18. LSIL Colposcopy Negative Unsatisfactory colpo No lesion Satisfactory Colpo Lesion in TZ ECC No CIN CIN 2,3 Cytology @ 6, 12 mths OR HPV testing Treat & Follow up
  • 19.
  • 21.
  • 22. HSIL Colposcopy ECC Unsatisfactory colpo Satisfactory Colpo No CIN 2,3 Diagnostic Excisional procedure Observe with Cytology / Colposcopy Treat & Follow up LEEP CIN 2,3
  • 23.
  • 24.
  • 25.
  • 26.
  • 27.
  • 29.
  • 30.
  • 31.
  • 32. AIS Hysterectomy preferred Margins involved ECC +ve Reexcision recommended Long term Follow up Diagnostic excisional procedure If future fertility desired Conservative Management Margins negative
  • 33.
  • 34.